253 related articles for article (PubMed ID: 30272500)
1. Models to Estimate the Probability of Malignancy in Patients with Pulmonary Nodules.
Choi HK; Ghobrial M; Mazzone PJ
Ann Am Thorac Soc; 2018 Oct; 15(10):1117-1126. PubMed ID: 30272500
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of models for predicting the probability of malignancy in patients with pulmonary nodules.
Li Y; Hu H; Wu Z; Yan G; Wu T; Liu S; Chen W; Lu Z
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32068231
[TBL] [Abstract][Full Text] [Related]
3. Risk of malignancy in pulmonary nodules: A validation study of four prediction models.
Al-Ameri A; Malhotra P; Thygesen H; Plant PK; Vaidyanathan S; Karthik S; Scarsbrook A; Callister ME
Lung Cancer; 2015 Jul; 89(1):27-30. PubMed ID: 25864782
[TBL] [Abstract][Full Text] [Related]
4. Role of biomarkers in lung nodule evaluation.
Sethi S; Cicenia J
Curr Opin Pulm Med; 2022 Jul; 28(4):275-281. PubMed ID: 35749790
[TBL] [Abstract][Full Text] [Related]
5. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
Li X; Zhang Q; Jin X; Cao L
World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
[TBL] [Abstract][Full Text] [Related]
6. Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation.
Tanner NT; Porter A; Gould MK; Li XJ; Vachani A; Silvestri GA
Chest; 2017 Aug; 152(2):263-270. PubMed ID: 28115167
[TBL] [Abstract][Full Text] [Related]
7. Estimating the probability of malignancy in solitary pulmonary nodules. A Bayesian approach.
Cummings SR; Lillington GA; Richard RJ
Am Rev Respir Dis; 1986 Sep; 134(3):449-52. PubMed ID: 3752700
[TBL] [Abstract][Full Text] [Related]
8. Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.
Massion PP; Healey GF; Peek LJ; Fredericks L; Sewell HF; Murray A; Robertson JF
J Thorac Oncol; 2017 Mar; 12(3):578-584. PubMed ID: 27615397
[TBL] [Abstract][Full Text] [Related]
9. A weighted rule based method for predicting malignancy of pulmonary nodules by nodule characteristics.
Kaya A; Can AB
J Biomed Inform; 2015 Aug; 56():69-79. PubMed ID: 26008877
[TBL] [Abstract][Full Text] [Related]
10. Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study.
Tanner NT; Aggarwal J; Gould MK; Kearney P; Diette G; Vachani A; Fang KC; Silvestri GA
Chest; 2015 Dec; 148(6):1405-1414. PubMed ID: 26087071
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary nodule characterization, including computer analysis and quantitative features.
Bartholmai BJ; Koo CW; Johnson GB; White DB; Raghunath SM; Rajagopalan S; Moynagh MR; Lindell RM; Hartman TE
J Thorac Imaging; 2015 Mar; 30(2):139-56. PubMed ID: 25658478
[TBL] [Abstract][Full Text] [Related]
12. [Advances and Clinical Application of Malignant Probability Prediction Models for
Solitary Pulmonary Nodule].
Wang Z; Zhao J; Wang M
Zhongguo Fei Ai Za Zhi; 2021 Sep; 24(9):660-667. PubMed ID: 34455736
[TBL] [Abstract][Full Text] [Related]
13. Coexisting pulmonary nodules in operable lung cancer: prevalence and probability of malignancy.
Ruppert AM; Lerolle U; Carette MF; Lavole A; Khalil A; Bazelly B; Antoine M; Cadranel J; Milleron B
Lung Cancer; 2011 Nov; 74(2):233-8. PubMed ID: 21511355
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a clinical prediction model to estimate the probability of malignancy in solitary pulmonary nodules in Chinese people.
Li Y; Chen KZ; Wang J
Clin Lung Cancer; 2011 Sep; 12(5):313-9. PubMed ID: 21889113
[TBL] [Abstract][Full Text] [Related]
15. The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules.
Mehta HJ; Ravenel JG; Shaftman SR; Tanner NT; Paoletti L; Taylor KK; Tammemagi MC; Gomez M; Nietert PJ; Gould MK; Silvestri GA
Chest; 2014 Mar; 145(3):464-472. PubMed ID: 23949741
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of clinicians and models for estimating the probability that a pulmonary nodule is malignant.
Balekian AA; Silvestri GA; Simkovich SM; Mestaz PJ; Sanders GD; Daniel J; Porcel J; Gould MK
Ann Am Thorac Soc; 2013 Dec; 10(6):629-35. PubMed ID: 24063427
[TBL] [Abstract][Full Text] [Related]
17. Return of the pulmonary nodule: the radiologist's key role in implementing the 2015 BTS guidelines on the investigation and management of pulmonary nodules.
Graham RN; Baldwin DR; Callister ME; Gleeson FV
Br J Radiol; 2016; 89(1059):20150776. PubMed ID: 26781558
[TBL] [Abstract][Full Text] [Related]
18. [Application of transbronchial navigation system in treatment of peripheral pulmonary nodules].
Wang LL; Li XY; Wang SY; Ye GL; Gao XL; Li J
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Feb; 42(2):140-144. PubMed ID: 30704190
[TBL] [Abstract][Full Text] [Related]
19. Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules.
Schultz EM; Sanders GD; Trotter PR; Patz EF; Silvestri GA; Owens DK; Gould MK
Thorax; 2008 Apr; 63(4):335-41. PubMed ID: 17965070
[TBL] [Abstract][Full Text] [Related]
20. The pulmonologist's perspective regarding the solitary pulmonary nodule.
Mazzone PJ; Stoller JK
Semin Thorac Cardiovasc Surg; 2002 Jul; 14(3):250-60. PubMed ID: 12232866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
